Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B.

@article{Kim2012VirologicRT,
  title={Virologic response to therapy increases health-related quality of life for patients with chronic hepatitis B.},
  author={Jeong Han Kim and So Young Kwon and Young Sok Lee and Joon Hyoek Lee and Yil-Seob Lee and Chang Hong Lee},
  journal={Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association},
  year={2012},
  volume={10 3},
  pages={291-6}
}
BACKGROUND & AIMS We evaluated changes in health-related quality of life (HRQoL) in a longitudinal study of patients given antiviral therapy for chronic hepatitis B (CHB). METHODS We analyzed changes in HRQoL reported by 2856 Korean patients with CHB who started first-line or rescue antiviral therapy from January 2007 to June 2007; the mean age of the study subjects was 43.3 years, 72% were male, 80% were positive for hepatitis B e antigen, 20% had cirrhosis, and 13% had concomitant disease… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 31 references

[EASL clinical practice guidelines. Management of chronic hepatitis B].

Gastroenterologie clinique et biologique • 2009

The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research • 2008

Health-related quality of life in patients with chronic hepatitis B.

Liver international : official journal of the International Association for the Study of the Liver • 2007

Similar Papers

Loading similar papers…